1,125 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ms-20 Non-Small Cell Lung Carcinoma	Microbio Co Ltd	N/A	NR ()
Nanocrystalline Megestrol Non-Small Cell Lung Carcinoma	Hunan Province Tumor Hospital	P3	NR ()
Nano-Crystalline Megestrol Acetate Suspension Non-Small Cell Lung Carcinoma	Changchun GeneScience Pharmaceutical Co., Ltd.	P3	NR ()
Nitroglycerin Tablets Non-Small Cell Lung Carcinoma	Instituto Nacional de Cancerologia de Mexico	P2	NR ()
nk010 Non-Small Cell Lung Carcinoma	The First Affiliated Hospital of Guangzhou Medical University	P1	NR ()
nxp900 Non-Small Cell Lung Carcinoma	Nuvectis Pharma, Inc.	P1	NR ()
Pevonedistat Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P2	NR ()
Pfizer-Biontech Mrna Covid-19 Vaccine Non-Small Cell Lung Carcinoma	University of Florida	P2	NR ()
ph009-1 Non-Small Cell Lung Carcinoma	Suzhou Puhe Pharmaceutical Technology Co., LTD	P1/2	NR ()
Puterizumab Non-Small Cell Lung Carcinoma	Sir Run Run Shaw Hospital	P2	NR ()
rx001 Non-Small Cell Lung Carcinoma	GeneCraft Inc.	P1	NR ()
sbt6050 Non-Small Cell Lung Carcinoma	Silverback Therapeutics	P1/2	NR ()
Sctb14 Non-Small Cell Lung Carcinoma	Sinocelltech Ltd.	P3	NR ()
Ssgj-706 Non-Small Cell Lung Carcinoma	Shenyang Sunshine Pharmaceutical Co., LTD.	P2	NR ()
Tak-500 Non-Small Cell Lung Carcinoma	Takeda	P1/2	NR ()
Tilelizumab Non-Small Cell Lung Carcinoma	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P3	NR ()
TJ271 Non-Small Cell Lung Carcinoma	TJ Biopharma Co., Ltd.	P2	NR ()
tno155 Non-Small Cell Lung Carcinoma	Novartis Pharmaceuticals	P1/2	NR ()
Vudalimab Non-Small Cell Lung Carcinoma	Xencor, Inc.	P1/2	NR ()
Wef-001 Non-Small Cell Lung Carcinoma	Auricula Biosciences Inc.	P1/2	NR ()
wsd0922-fu Non-Small Cell Lung Carcinoma	Wayshine Biopharm, Inc.	P2	NR ()
Xingbaiji Formula Non-Small Cell Lung Carcinoma	Jiangxi Provincial People's Hopital	N/A	NR ()
Xmab808 Non-Small Cell Lung Carcinoma	Xencor, Inc.	P1	NR ()
Xmt-2056 Non-Small Cell Lung Carcinoma	Day One Biopharmaceuticals, Inc.	P1	NR ()
yk-209a Non-Small Cell Lung Carcinoma	Suzhou Puhe Pharmaceutical Technology Co., LTD	P3	NR ()

Showing 1101 to 1125 of 1,125 assets

PreviousPage 23 of 23Next